Black Cameron R M, Goriainov Vitali, Gibbs David, Kanczler Janos, Tare Rahul S, Oreffo Richard O C
Bone and Joint Research Group, Centre for Human Development, Stem Cells and Regeneration, Developmental Origins of Health and Disease, Institute of Developmental Sciences, University of Southampton Medical School, Southampton, SO16 6YD UK.
Curr Mol Biol Rep. 2015;1(3):132-140. doi: 10.1007/s40610-015-0022-2. Epub 2015 Aug 15.
Medical advances have led to a welcome increase in life expectancy. However, accompanying longevity introduces new challenges: increases in age-related diseases and associated reductions in quality of life. The loss of skeletal tissue that can accompany trauma, injury, disease or advancing years can result in significant morbidity and significant socio-economic cost and emphasise the need for new, more reliable skeletal regeneration strategies. To address the unmet need for bone augmentation, tissue engineering and regenerative medicine have come to the fore in recent years with new approaches for de novo skeletal tissue formation. Typically, these approaches seek to harness stem cells, innovative scaffolds and biological factors that promise enhanced and more reliable bone formation strategies to improve the quality of life for many. This review provides an overview of recent developments in bone tissue engineering focusing on skeletal stem cells, vascular development, bone formation and the translation from preclinical in vivo models to clinical delivery.
医学进步使得预期寿命可喜地增加。然而,随之而来的长寿带来了新的挑战:与年龄相关的疾病增加以及生活质量相应下降。创伤、损伤、疾病或年龄增长可能伴随的骨骼组织丧失会导致严重的发病率和巨大的社会经济成本,并凸显了对新的、更可靠的骨骼再生策略的需求。为了满足骨增量的未满足需求,近年来组织工程和再生医学崭露头角,出现了从头开始形成骨骼组织的新方法。通常,这些方法试图利用干细胞、创新支架和生物因子,有望实现增强且更可靠的骨形成策略,从而改善许多人的生活质量。本综述概述了骨组织工程的最新进展,重点关注骨骼干细胞、血管发育、骨形成以及从临床前体内模型到临床应用的转化。